Drugs Made In America Acquisition II Corp. Ordinary Shares Defensive Interval Ratio

Latest as of September 2025: 305 days

Drugs Made In America Acquisition II Corp. Ordinary Shares defensive interval ratio. Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Defensive Interval Ratio of 305 days as of September 2025. Defensive assets of $566.27K (cash $-, short-term investments $-, receivables $566.27K) cover 305 days of daily cash needs of $1.86K/day. See Drugs Made In America Acquisition II Cor working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

305 days
Days of operational coverage

Defensive Assets

$566.27K
Cash + ST Investments + Receivables

Daily Cash Need

$1.86K
Current Liabilities ÷ 365

Current Liabilities

$677.35K
USD

Drugs Made In America Acquisition II Corp. Ordinary Shares Defensive Interval Ratio by Year (None–None)

Drugs Made In America Acquisition II Corp. Ordinary Shares defensive interval ratio by year from None to None. The table below presents the year-by-year Defensive Interval Ratio for Drugs Made In America Acquisition II Corp. Ordinary Shares from None to None, covering 0 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of Drugs Made In America Acquisition II Cor.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)